StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens lifted their price objective on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
View Our Latest Research Report on Veradigm
Veradigm Trading Down 4.4 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Short Selling – The Pros and Cons
- Can TikTok Stock Picks Really Make You Rich?
- Why Invest in 5G? How to Invest in 5G Stocks
- The “Quality” Rotation: Back to Basics Investing
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
